GSA Capital Partners’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,923
Closed -$380K 1894
2021
Q2
$380K Buy
10,923
+6,145
+129% +$244K 0.04% 801
2021
Q1
$230K Sell
4,778
-2,977
-38% -$173K 0.04% 813
2020
Q4
$376K Buy
7,755
+6,642
+597% +$250K 0.06% 615
2020
Q3
$39K Buy
+1,113
New +$62.7K 0.01% 1196
2017
Q4
Sell
-4,840
Closed -$299K 1894
2017
Q3
$299K Buy
4,840
+2,940
+155% +$172K 0.02% 1254
2017
Q2
$121K Buy
+1,900
New +$105K 0.01% 1574

Other funds holding NH

GSA Capital Partners's NH Position: Q3 2021 in Review

GSA Capital Partners sold out of NantHealth, Inc (NH) in Q3 2021, closing a stake of 10,923 shares — an estimated $380K sold.

GSA Capital Partners first reported a position in NH in Q2 2017 and held it in 6 quarters. The position peaked at $380K in Q2 2021. 44 funds tracked by Wall St. Rank hold NH as of Q3 2021.

  • GSA Capital Partners reported no remaining NantHealth, Inc position as of Q3 2021 after selling out during the quarter.
  • GSA Capital Partners sold 10,923 NantHealth, Inc shares in Q3 2021, an estimated $380K.
  • GSA Capital Partners first reported a position in NantHealth, Inc in Q2 2017 and held it in 6 quarters.
  • GSA Capital Partners's NantHealth, Inc position peaked at $380K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2021.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.